SRC and head and neck squamous cell carcinoma: Integrin β6, which is neoexpressed in SCCHN, has been found to activate Fyn but not c-Src or c-Yes in SCCHN upon ligation with fibronectin, leading to Fyn-dependent activation of the Raf-ERK/MAPK pathway [73].